A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Catching up with Lonza Capsules and Health Ingredients - Nutritional Outlook
Catching up with Lonza Capsules and Health Ingredients Nutritional Outlook
Illumina aims to cut $100M in costs following China import ban - Fierce Biotech
Illumina aims to cut $100M in costs following China import ban Fierce Biotech
Illumina addresses recent developments in China - PR Newswire
Illumina addresses recent developments in China PR Newswire
Illumina’s DNA sequencers hit with China import ban - MedTech Dive
Illumina’s DNA sequencers hit with China import ban MedTech Dive
Illumina placed on China’s unreliable entity list - MedTech Dive
Illumina placed on China’s unreliable entity list MedTech Dive
CDMO Joinn Biologics snaps up China biologics plant from Lonza in push to tackle Asia-Pacific market - Fierce Pharma
CDMO Joinn Biologics snaps up China biologics plant from Lonza in push to tackle Asia-Pacific market Fierce Pharma
JPM 2025: Lonza shares outlook on CHI exit and acquisition strategy - Pharmaceutical Technology
JPM 2025: Lonza shares outlook on CHI exit and acquisition strategy Pharmaceutical Technology
Cytiva acquires Michigan plant from BASF - BioProcess Insider - BioProcess International
FACILITIES & CAPACITY BIOPROCESS INSIDER NEWS Cytiva bolsters resin operations outside of Sweden with Michigan plant buy Cytiva has invested in resins production outsid...
Cytiva makes good on China single-use expansion - BioProcess International
Cytiva makes good on China single-use expansion BioProcess International
Michigan board combines $3M in grants for $430M life sciences plant near Muskegon - MLive.com
Michigan board combines $3M in grants for $430M life sciences plant near Muskegon MLive.com